Second Sight Medical (EYES) Picks Up Chatter Ahead of CNBC Coverage

While off the highs, traders are getting chatty about today's IPO for Second Sight Medical Products (NASDAQ: EYES) as it is expected to be highlighted on CNBC in a little while. Shares are up 105% at last check to $18.50 after pricing at $9.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
• B. Riley Financial (RILY) touching day low of $27, giving back half the day's gains